Filing Flows › Comparisons › DYAI vs PRME
Dyadic International vs Prime Medicine: DYAI and PRME compared
Dyadic International is the larger company: $961K of revenue in its latest quarter (Q2 2026) against $838K for Prime Medicine (Q4 2025). Dyadic International is growing faster (-0.6% against -62% a year earlier).
Where the money goes: DYAI and PRME
Dyadic International (DYAI) · Q2 2026
Dyadic International, Q2 2026: revenue $961K (-0.6% year over year), operating margin -213.7%, net loss $2.1M, operating cash flow −$1.8M. The chart follows the revenue to costs, profit and cash.
Prime Medicine (PRME) · Q4 2025
Prime Medicine, Q4 2025: revenue $838K (-62% year over year), net loss $46.1M, operating cash flow −$37.3M. The chart follows the revenue to costs, profit and cash.
| Dyadic International (DYAI) | Prime Medicine (PRME) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q4 2025 |
| Revenue | $961K | $838K |
| Revenue growth, Y/Y | -0.6% | -62% |
| Operating margin | -213.7% | n/m |
| Net earnings | −$2.1M | −$46.1M |
| Net margin | -221.0% | — |
| Operating cash flow | −$1.8M | −$37.3M |
Where the revenue comes from
Dyadic International
- Grant: $837K (87%)
- Research and Development: $124K (13%)
Questions
Which is bigger, Dyadic International or Prime Medicine?
Dyadic International is the larger company: $961K of revenue in its latest quarter (Q2 2026) against $838K for Prime Medicine (Q4 2025).
Is Dyadic International or Prime Medicine growing faster?
Dyadic International is growing faster (-0.6% against -62% a year earlier).
More: Dyadic International earnings · how Dyadic International makes money · Prime Medicine earnings · how Prime Medicine makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 12, 2026; 10-K filed Mar 3, 2026). Fiscal quarters can end on different dates. Not investment advice.